EGFR antisense RNA blocks expression of the epidermal growth factor receptor and partially reverse the malignant phenotype of human breast cancer MDA-MB-231 cells

Cell Research

Volumn 8, Issue 1, 1998, Pages 63-71

  Fan, Wen Hong ^a   Lu, Ying Lin ^a   Deng, Fan ^a   Ge, Xue Ming ^a   Liu, Shuang ^a   Tang, Pei Hesin ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

Antisense RNA; EGFR; Gene transfection; Human breast cancer cells

Indexed keywords

COMPLEMENTARY RNA; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; FIBRONECTIN; LAMININ;

ARTICLE; BREAST TUMOR; CELL ADHESION; CELL CULTURE; CELL CYCLE; CELL DIVISION; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HUMAN; PATHOLOGY; PHENOTYPE; PHYSIOLOGY;

BREAST NEOPLASMS; CELL ADHESION; CELL CYCLE; CELL DIVISION; EPIDERMAL GROWTH FACTOR; FIBRONECTINS; GENE EXPRESSION REGULATION; HUMANS; LAMININ; PHENOTYPE; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, ANTISENSE; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0032016685     PISSN: 10010602     EISSN: None     Source Type: Journal    
DOI: 10.1038/cr.1998.7     Document Type: Article

References (16)

1. Gill GN, Bertics PJ, Santon JB. Epidermal growth factor and its receptor. Molecular andCellular Endocrinology 1987; 51:169-86.
2. Koenders P, Beex L, Kienhuis C. et al. Epidermal growth factor and receptor and prognosis inhuman breast cancer: a prospective study. Breast Cancer Res Treat 1992; 23:134.
3. Huang S, Lin PF, Fan D, et al. Growth modulation by EGF in human colonic carcinoma cells:constitutive expression of the human EGF gene. J Cell Physiol 1991; 148:220-7.
4. Delaru JC, Friedman S, Mouriesse H, et al. EGFR in breast cancers: correlation with estrogenand progesterone receptors. Breast Cancer Res Treat 1988; 11:173-8.
5. Chakrabarty S, Rajagopal S, Shuang Huang. Expression of antisense epidermal growth factorreceptor RNA down modulates the malignant behavior of human colon cancer cells. Clin ExpMetastasis 1995; 13:191-5.
6. Giovanni CD, Landuzzi L, Frabetti F, et al. Antisense EGFR transfection impairs the proliferative ability of human rhabdomyosarcoma cells. Cancer Res 1996; 56:3898-3901.
7. Moroni MC, Willingham MC, Beguino L. EGF-R antisense RNA blocks expression of the epidermal growth factor receptor and suppresses the transforming phenotype of a human carcinomacell line. J Biol Chem 1992; 267(5):2714-22.
8. Xu YH, WL Jiang, SF Peng, YH Cheng. Antisense EGF receptor sequence reverses the growthproperties of human liver carcinoma cell line. Cell Research 1993; 3:75-83.
9. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. 2nd ed. NewYork: Cold Spring Harbor Laboratory Press. 1989.
10. E Zh, Chen QG, Xu XL, et al. Tissue Culture Technology. 2nd ed. Beijing: People HygienePress. 1993.
11. Kopper L and Kovalszkg I. Antisense tumor therapy. In Vivo 1994; 8: 781-6.
12. Muller H, Loop P, Liu R, et al. Differential signal transduction of epidermal-growth-factorreceptor in hormone-dependent and hormone-independent human breast cancer cells. Eur JBiochem 1994; 221:631-7.
13. Valverius EM, Velu T, Shankar N, et al. Over-expression of the epidermal growth factor receptorin human breast cancer cells fails to induce an estrogen-independent phenotype. Int J Cancer1990; 46:712-18.
14. Davidson NE, Gelmann EP , Lippman ME, et al. Epidermal growth factor receptor gene expression in estrogen receptor-positive and -negative human breast cancer cell lines. Mol Endocrinol1987; 1:216-23.
15. Liotta LA. Tumor invasion and metastases role of extracellular matrix. Cancer Res 1986; 46:1-7.
16. Akiyama SK, Olden K, Uamade KM. Fibronectin and integrins in invasion and metastasis.Cancer Metastasis Rev 1995; 14:173-89.